Hoffmann-La Roche is a pharmaceutical company focusing on the research, development, and production of innovative healthcare solutions. It was founded in 1896 and is currently led by CEO Thomas Schinecker. Major products and brands associated with the company include well-known medications such as Valium, Tamiflu, and Accutane.
The company employs over 101,200 people from diverse demographic backgrounds, with 48.7% female employees and 47.9% ethnic minorities. It has its headquarters in New Jersey and generates $60.9 billion in annual revenue. Hoffmann-La Roche is dedicated to delivering medical solutions urgently while also developing innovations for the future. Its mission is to transform patients' lives, demonstrate courage in decision-making and action, and strive for a better world through ethical business practices.
